Showing results (921-930 of 5,689) with videos related to

Sort By:
Pageof 569
The Oncologist|December 8, 2020
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell TumorsJames H Lewis, Hans Gelderblom, Michiel van de Sande, et al.
The Oncologist|December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal TumorsCissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
The Oncologist|November 16, 2020
More Insights on the Use of γ-Secretase Inhibitors in Cancer TreatmentPilar López-Nieva, Laura González-Sánchez, María Ángeles Cobos-Fernández, et al.
The Oncologist|October 12, 2020
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient SettingSienna M Durbin, Leyre Zubiri, Andrzej Niemierko, et al.
The Oncologist|November 12, 2020
2020 Innovation-Based Optimism for Lung Cancer OutcomesErin L Schenk, Tejas Patil, Jose Pacheco, et al.
The Oncologist|July 7, 2021
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational StudyKeigo Chida, Daisuke Kotani, Toshiki Masuishi, et al.
The Oncologist|May 27, 2021
Mosaicism for Receptor Tyrosine Kinase Activation in a Glioblastoma Involving Both PDGFRA Amplification and NTRK2 FusionDaniel J Shepherd, Tyler E Miller, Deborah A Forst, et al.
The Oncologist|July 6, 2022
Burden of Cancer and Utilization of Local Surgical Treatment Services in Rural Hospitals of Ethiopia: A Retrospective Assessment from 2014 to 2019Abigiya Wondimagegnehu, Fekadu Negash Bereded, Mathewos Assefa, et al.
The Oncologist|July 26, 2021
Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled TrialWenjie Ni, Shufei Yu, Zefen Xiao, et al.
The Oncologist|November 27, 2020
A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Patients with Advanced Breast Cancer After First-Line ChemotherapyFei Xu, Qiufan Zheng, Wen Xia, et al.
Pageof 569